Gilead Sciences Inc

More

• Final Glance: Biotechnology companies Friday, 24 May 2013 | 6:03 PM ET

  Amgen Inc. rose$. 29 or. 3 percent, to $105.91. Biogen Idec rose $2.62 or 1.1 percent, to $235.24. Celgene Corp. fell $1.06 or. 9 percent, to $122.58.

• Midday Glance: Biotechnology companies Friday, 24 May 2013 | 1:17 PM ET

  Amgen Inc. fell$. 16 or. 2 percent, to $105.46. Biogen Idec fell$. 30 or. 1 percent, to $232.32. Celgene Corp. fell $1.47 or 1.2 percent, to $122.18.

• Early Glance: Biotechnology companies Friday, 24 May 2013 | 10:32 AM ET

  Amgen Inc. fell$. 87 or. 8 percent, to $104.75. Biogen Idec fell $2.02 or. 9 percent, to $230.61. Celgene Corp. fell$. 91 or. 7 percent, to $122.73.

• Final Glance: Biotechnology companies Thursday, 23 May 2013 | 6:03 PM ET

  Amgen Inc. rose $1.09 or 1.0 percent, to $105.62. Biogen Idec fell$. 45 or. 2 percent, to $232.62. Gilead Sciences Inc. fell$. 45 or. 8 percent, to $55.48.

• Midday Glance: Biotechnology companies Thursday, 23 May 2013 | 1:46 PM ET

  Amgen Inc. rose $1.32 or 1.3 percent, to $105.85. Biogen Idec rose$. 79 or. 3 percent, to $233.86. Celgene Corp. rose $1.03 or. 8 percent, to $124.47.

• Early Glance: Biotechnology companies Thursday, 23 May 2013 | 10:45 AM ET

  Amgen Inc. fell$. 78 or. 7 percent, to $103.75. Biogen Idec fell $4.46 or 1.9 percent, to $228.61. Celgene Corp. fell $2.11 or 1.7 percent, to $121.33.

• Final Glance: Biotechnology companies Wednesday, 22 May 2013 | 6:07 PM ET

  Amgen Inc. rose$. 29 or. 3 percent, to $104.53. Biogen Idec rose $1.74 or. 8 percent, to $233.07. Celgene Corp. fell$. 06 or percent, to $123.44.

• Midday Glance: Biotechnology companies Wednesday, 22 May 2013 | 1:17 PM ET

  Amgen Inc. rose $1.86 or 1.8 percent, to $106.10. Biogen Idec rose $4.67 or 2.0 percent, to $236.00. Celgene Corp. rose $2.58 or 2.1 percent, to $126.08.

• Early Glance: Biotechnology companies Wednesday, 22 May 2013 | 10:50 AM ET

  Amgen Inc. rose $1.92 or 1.8 percent, to $106.16. Biogen Idec rose $5.38 or 2.3 percent, to $236.71. Celgene Corp. rose $4.10 or 3.3 percent, to $127.60.

• Final Glance: Biotechnology companies Tuesday, 21 May 2013 | 8:50 PM ET

  Amgen Inc. rose $2.06 or 2.0 percent, to $104.24. Biogen Idec rose $6.15 or 2.7 percent, to $231.33. Celgene Corp. rose$. 38 or. 3 percent, to $123.50.

• Midday Glance: Biotechnology companies Tuesday, 21 May 2013 | 1:16 PM ET

  Amgen Inc. rose $1.72 or 1.7 percent, to $103.90. Biogen Idec rose $6.90 or 3.1 percent, to $232.08. Celgene Corp. fell$. 27 or. 2 percent, to $122.85.

• Early Glance: Biotechnology companies Tuesday, 21 May 2013 | 10:36 AM ET

  Amgen Inc. rose $2.04 or 2.0 percent, to $104.22. Biogen Idec rose $5.56 or 2.5 percent, to $230.74. Celgene Corp. rose $1.03 or. 8 percent, to $124.15.

• Cramer’s Watch List Ahead of Big Cancer Conference Monday, 20 May 2013 | 6:26 PM ET

  

  The ASCO meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer.

• Final Glance: Biotechnology companies Monday, 20 May 2013 | 6:04 PM ET

  Amgen Inc. fell $3.45 or 3.3 percent, to $102.18. Biogen Idec fell $1.67 or. 7 percent, to $225.18. Celgene Corp. fell $1.79 or 1.4 percent, to $123.12.

• Midday Glance: Biotechnology companies Monday, 20 May 2013 | 1:16 PM ET

  Amgen Inc. fell $3.37 or 3.2 percent, to $102.26. Biogen Idec fell$. 36 or. 2 percent, to $226.49. Celgene Corp. fell $1.18 or. 9 percent, to $123.73.

• Early Glance: Biotechnology companies Monday, 20 May 2013 | 10:31 AM ET

  Amgen Inc. fell $1.36 or 1.3 percent, to $104.28. Biogen Idec rose $5.05 or 2.2 percent, to $231.90. Celgene Corp. fell$. 33 or. 3 percent, to $124.58.

• Final Glance: Biotechnology companies Friday, 17 May 2013 | 6:03 PM ET

  Amgen Inc. rose$. 66 or. 6 percent, to $105.63. Biogen Idec fell $1.14 or. 5 percent, to $226.85. Celgene Corp. rose $1.43 or 1.2 percent, to $124.91.

• Midday Glance: Biotechnology companies Friday, 17 May 2013 | 1:32 PM ET

  Amgen Inc. fell$. 13 or. 1 percent, to $104.84. Biogen Idec fell $3.07 or 1.3 percent, to $224.92. Celgene Corp. fell$. 34 or. 3 percent, to $123.14.

• Early Glance: Biotechnology companies Friday, 17 May 2013 | 10:25 AM ET

  Amgen Inc. rose$. 64 or. 6 percent, to $105.61. Biogen Idec fell $1.82 or. 8 percent, to $226.17. Celgene Corp. rose$. 43 or. 3 percent, to $123.91.

• Lightning Round: Starbucks, Gilead & More Thursday, 16 May 2013 | 6:42 PM ET

  

  It’s time for the Lightning Round. Cramer makes the call on viewer favorites.